S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in

BIT:DIA - DiaSorin Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume56,054 shs
Average Volume113,340 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. The company offers tests for diagnosis in a range of clinical areas, such as infectious diseases, gastrointestinal infections, bone and mineral metabolism, endocrinology, hypertension, oncology, onco-hematology, and autoimmunity. It also provides various technological platforms, including LIAISON XL and LIAISON XS analyzer systems; and LIAISON MDX instrument, a thermocycler. The company sells its products directly, as well as through an international network of independent distributors. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Industry, Sector and Symbol

Industry Medical Laboratories & Research



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A

Receive DIA News and Ratings via Email

Sign-up to receive the latest news and ratings for DIA and its competitors with MarketBeat's FREE daily newsletter.

DiaSorin (BIT:DIA) Frequently Asked Questions

What is DiaSorin's stock symbol?

DiaSorin trades on the BIT under the ticker symbol "DIA."

Has DiaSorin been receiving favorable news coverage?

Media headlines about DIA stock have trended somewhat positive this week, InfoTrie reports. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DiaSorin earned a news impact score of 1.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for DiaSorin.

Who are some of DiaSorin's key competitors?

Who are DiaSorin's key executives?

DiaSorin's management team includes the folowing people:
  • Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)
  • Dr. Chen Menachem Even, Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Director (Age 56)
  • Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)
  • Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
  • Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department

What is DiaSorin's official website?

The official website for DiaSorin is http://www.diasorin.com/.

How can I contact DiaSorin?

DiaSorin's mailing address is via Crescentino snc, SALUGGIA, 13040, Italy. The company can be reached via phone at +39-0161-487526.

MarketBeat Community Rating for DiaSorin (BIT DIA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  70 (Vote Underperform)
Total Votes:  166
MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote "Outperform" if you believe DIA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DIA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel